Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IntelliCell Biosciences Inc files Pre-IND With FDA for Osteoarthritis

Friday, 1 Aug 2014 01:53pm EDT 

IntelliCell BioSciences Inc:Filed its pre-IND with the FDA for a clinical trial in osteoarthritis of the knee under an Investigational New Drug Application.Says it will serve as the Clinical Research Organization (CRO) for the conduction of this clinical trial in osteoarthritis of the knee in accordance of an Investigational New Drug. 

Company Quote

1.0E-4 +100.00%
1 Jul 2015